Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pain × Ketamine × Clear all

Phase

Phase 3 5 Phase 4 3 Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Head and Neck Neoplasms 2 Depression 2 Breast Neoplasms 2 Stomatitis 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Lung Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Cancer Pain 1 Anxiety Disorders 1 Agnosia 1

Interventions

Analgesia 6 Morphine 5 Pregabalin 3 Oxycodone 3 Fentanyl 3 ziconotide 2 nabiximols 2 Surveys and Questionnaires 2 Saline Solution 2 Radiofrequency Ablation 2 Methadone 2 Lidocaine 2 Ibandronic Acid 2 Duloxetine Hydrochloride 2 Docetaxel 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tanezumab 1 tandutinib 1 siltuximab 1 resiniferatoxin 1 incobotulinumtoxinA 1 imisopasem manganese 1 fulranumab 1 erenumab 1 cyclobenzaprine 1 caffeine, sodium benzoate drug combination 1 Therapeutics 1 Tapentadol 1 Sulindac 1 Soybean Proteins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00304850 2009-12-29

PoLyDOL

University Hospital, Bordeaux

Phase 2 Completed

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡